Global Androstenedione and Derivatives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Androstenedione and Derivatives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 83

Published Date: 02 Oct 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).

Androstenedione derivatives refer to steroid hormone intermediates produced with androstenedione as the starting material, including testosterone, 17-hydroxyprogesterone, progesterone, canrenone, spironolactone, nandrolone, estrone, estradiol, estriol, etc.

According to our (Global Info Research) latest study, the global Androstenedione and Derivatives market size was valued at US$ 150 million in 2023 and is forecast to a readjusted size of USD 216 million by 2030 with a CAGR of 5.2% during review period.

This report is a detailed and comprehensive analysis for global Androstenedione and Derivatives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Androstenedione and Derivatives market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Androstenedione and Derivatives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Androstenedione and Derivatives market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Androstenedione and Derivatives market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Androstenedione and Derivatives
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Androstenedione and Derivatives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hubei Goto Biopharm, Saituo Biological Technology, Bayer, Rifa Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Androstenedione and Derivatives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Androstenedione
Androstenedione Derivatives

Market segment by Application
Sex Hormone Intermediates
Progesterone Intermediates

Major players covered
Hubei Goto Biopharm
Saituo Biological Technology
Bayer
Rifa Pharma

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Androstenedione and Derivatives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Androstenedione and Derivatives, with price, sales quantity, revenue, and global market share of Androstenedione and Derivatives from 2019 to 2024.
Chapter 3, the Androstenedione and Derivatives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Androstenedione and Derivatives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Androstenedione and Derivatives market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Androstenedione and Derivatives.
Chapter 14 and 15, to describe Androstenedione and Derivatives sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Androstenedione and Derivatives Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Androstenedione
1.3.3 Androstenedione Derivatives
1.4 Market Analysis by Application
1.4.1 Overview: Global Androstenedione and Derivatives Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Sex Hormone Intermediates
1.4.3 Progesterone Intermediates
1.5 Global Androstenedione and Derivatives Market Size & Forecast
1.5.1 Global Androstenedione and Derivatives Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Androstenedione and Derivatives Sales Quantity (2019-2030)
1.5.3 Global Androstenedione and Derivatives Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Hubei Goto Biopharm
2.1.1 Hubei Goto Biopharm Details
2.1.2 Hubei Goto Biopharm Major Business
2.1.3 Hubei Goto Biopharm Androstenedione and Derivatives Product and Services
2.1.4 Hubei Goto Biopharm Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Hubei Goto Biopharm Recent Developments/Updates
2.2 Saituo Biological Technology
2.2.1 Saituo Biological Technology Details
2.2.2 Saituo Biological Technology Major Business
2.2.3 Saituo Biological Technology Androstenedione and Derivatives Product and Services
2.2.4 Saituo Biological Technology Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Saituo Biological Technology Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Androstenedione and Derivatives Product and Services
2.3.4 Bayer Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Rifa Pharma
2.4.1 Rifa Pharma Details
2.4.2 Rifa Pharma Major Business
2.4.3 Rifa Pharma Androstenedione and Derivatives Product and Services
2.4.4 Rifa Pharma Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Rifa Pharma Recent Developments/Updates

3 Competitive Environment: Androstenedione and Derivatives by Manufacturer
3.1 Global Androstenedione and Derivatives Sales Quantity by Manufacturer (2019-2024)
3.2 Global Androstenedione and Derivatives Revenue by Manufacturer (2019-2024)
3.3 Global Androstenedione and Derivatives Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Androstenedione and Derivatives by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Androstenedione and Derivatives Manufacturer Market Share in 2023
3.4.3 Top 6 Androstenedione and Derivatives Manufacturer Market Share in 2023
3.5 Androstenedione and Derivatives Market: Overall Company Footprint Analysis
3.5.1 Androstenedione and Derivatives Market: Region Footprint
3.5.2 Androstenedione and Derivatives Market: Company Product Type Footprint
3.5.3 Androstenedione and Derivatives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Androstenedione and Derivatives Market Size by Region
4.1.1 Global Androstenedione and Derivatives Sales Quantity by Region (2019-2030)
4.1.2 Global Androstenedione and Derivatives Consumption Value by Region (2019-2030)
4.1.3 Global Androstenedione and Derivatives Average Price by Region (2019-2030)
4.2 North America Androstenedione and Derivatives Consumption Value (2019-2030)
4.3 Europe Androstenedione and Derivatives Consumption Value (2019-2030)
4.4 Asia-Pacific Androstenedione and Derivatives Consumption Value (2019-2030)
4.5 South America Androstenedione and Derivatives Consumption Value (2019-2030)
4.6 Middle East & Africa Androstenedione and Derivatives Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
5.2 Global Androstenedione and Derivatives Consumption Value by Type (2019-2030)
5.3 Global Androstenedione and Derivatives Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
6.2 Global Androstenedione and Derivatives Consumption Value by Application (2019-2030)
6.3 Global Androstenedione and Derivatives Average Price by Application (2019-2030)

7 North America
7.1 North America Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
7.2 North America Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
7.3 North America Androstenedione and Derivatives Market Size by Country
7.3.1 North America Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
7.3.2 North America Androstenedione and Derivatives Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
8.2 Europe Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
8.3 Europe Androstenedione and Derivatives Market Size by Country
8.3.1 Europe Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
8.3.2 Europe Androstenedione and Derivatives Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Androstenedione and Derivatives Market Size by Region
9.3.1 Asia-Pacific Androstenedione and Derivatives Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Androstenedione and Derivatives Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
10.2 South America Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
10.3 South America Androstenedione and Derivatives Market Size by Country
10.3.1 South America Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
10.3.2 South America Androstenedione and Derivatives Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Androstenedione and Derivatives Market Size by Country
11.3.1 Middle East & Africa Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Androstenedione and Derivatives Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Androstenedione and Derivatives Market Drivers
12.2 Androstenedione and Derivatives Market Restraints
12.3 Androstenedione and Derivatives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Androstenedione and Derivatives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Androstenedione and Derivatives
13.3 Androstenedione and Derivatives Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Androstenedione and Derivatives Typical Distributors
14.3 Androstenedione and Derivatives Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Androstenedione and Derivatives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Androstenedione and Derivatives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Hubei Goto Biopharm Basic Information, Manufacturing Base and Competitors
Table 4. Hubei Goto Biopharm Major Business
Table 5. Hubei Goto Biopharm Androstenedione and Derivatives Product and Services
Table 6. Hubei Goto Biopharm Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Hubei Goto Biopharm Recent Developments/Updates
Table 8. Saituo Biological Technology Basic Information, Manufacturing Base and Competitors
Table 9. Saituo Biological Technology Major Business
Table 10. Saituo Biological Technology Androstenedione and Derivatives Product and Services
Table 11. Saituo Biological Technology Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Saituo Biological Technology Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Androstenedione and Derivatives Product and Services
Table 16. Bayer Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Rifa Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Rifa Pharma Major Business
Table 20. Rifa Pharma Androstenedione and Derivatives Product and Services
Table 21. Rifa Pharma Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Rifa Pharma Recent Developments/Updates
Table 23. Global Androstenedione and Derivatives Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 24. Global Androstenedione and Derivatives Revenue by Manufacturer (2019-2024) & (USD Million)
Table 25. Global Androstenedione and Derivatives Average Price by Manufacturer (2019-2024) & (US$/kg)
Table 26. Market Position of Manufacturers in Androstenedione and Derivatives, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 27. Head Office and Androstenedione and Derivatives Production Site of Key Manufacturer
Table 28. Androstenedione and Derivatives Market: Company Product Type Footprint
Table 29. Androstenedione and Derivatives Market: Company Product Application Footprint
Table 30. Androstenedione and Derivatives New Market Entrants and Barriers to Market Entry
Table 31. Androstenedione and Derivatives Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Androstenedione and Derivatives Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 33. Global Androstenedione and Derivatives Sales Quantity by Region (2019-2024) & (Tons)
Table 34. Global Androstenedione and Derivatives Sales Quantity by Region (2025-2030) & (Tons)
Table 35. Global Androstenedione and Derivatives Consumption Value by Region (2019-2024) & (USD Million)
Table 36. Global Androstenedione and Derivatives Consumption Value by Region (2025-2030) & (USD Million)
Table 37. Global Androstenedione and Derivatives Average Price by Region (2019-2024) & (US$/kg)
Table 38. Global Androstenedione and Derivatives Average Price by Region (2025-2030) & (US$/kg)
Table 39. Global Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 40. Global Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 41. Global Androstenedione and Derivatives Consumption Value by Type (2019-2024) & (USD Million)
Table 42. Global Androstenedione and Derivatives Consumption Value by Type (2025-2030) & (USD Million)
Table 43. Global Androstenedione and Derivatives Average Price by Type (2019-2024) & (US$/kg)
Table 44. Global Androstenedione and Derivatives Average Price by Type (2025-2030) & (US$/kg)
Table 45. Global Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 46. Global Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 47. Global Androstenedione and Derivatives Consumption Value by Application (2019-2024) & (USD Million)
Table 48. Global Androstenedione and Derivatives Consumption Value by Application (2025-2030) & (USD Million)
Table 49. Global Androstenedione and Derivatives Average Price by Application (2019-2024) & (US$/kg)
Table 50. Global Androstenedione and Derivatives Average Price by Application (2025-2030) & (US$/kg)
Table 51. North America Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 52. North America Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 53. North America Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 54. North America Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 55. North America Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 56. North America Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 57. North America Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 58. North America Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Europe Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 60. Europe Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 61. Europe Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 62. Europe Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 63. Europe Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 64. Europe Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 65. Europe Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 66. Europe Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 67. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 68. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 69. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 70. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 71. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Region (2019-2024) & (Tons)
Table 72. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Region (2025-2030) & (Tons)
Table 73. Asia-Pacific Androstenedione and Derivatives Consumption Value by Region (2019-2024) & (USD Million)
Table 74. Asia-Pacific Androstenedione and Derivatives Consumption Value by Region (2025-2030) & (USD Million)
Table 75. South America Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 76. South America Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 77. South America Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 78. South America Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 79. South America Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 80. South America Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 81. South America Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 84. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 85. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 86. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 87. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 88. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 89. Middle East & Africa Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Middle East & Africa Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Androstenedione and Derivatives Raw Material
Table 92. Key Manufacturers of Androstenedione and Derivatives Raw Materials
Table 93. Androstenedione and Derivatives Typical Distributors
Table 94. Androstenedione and Derivatives Typical Customers


List of Figures
Figure 1. Androstenedione and Derivatives Picture
Figure 2. Global Androstenedione and Derivatives Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Androstenedione and Derivatives Revenue Market Share by Type in 2023
Figure 4. Androstenedione Examples
Figure 5. Androstenedione Derivatives Examples
Figure 6. Global Androstenedione and Derivatives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Androstenedione and Derivatives Revenue Market Share by Application in 2023
Figure 8. Sex Hormone Intermediates Examples
Figure 9. Progesterone Intermediates Examples
Figure 10. Global Androstenedione and Derivatives Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Androstenedione and Derivatives Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Androstenedione and Derivatives Sales Quantity (2019-2030) & (Tons)
Figure 13. Global Androstenedione and Derivatives Price (2019-2030) & (US$/kg)
Figure 14. Global Androstenedione and Derivatives Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Androstenedione and Derivatives Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Androstenedione and Derivatives by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 Androstenedione and Derivatives Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 Androstenedione and Derivatives Manufacturer (Revenue) Market Share in 2023
Figure 19. Global Androstenedione and Derivatives Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Androstenedione and Derivatives Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Androstenedione and Derivatives Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Androstenedione and Derivatives Average Price by Type (2019-2030) & (US$/kg)
Figure 29. Global Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Androstenedione and Derivatives Revenue Market Share by Application (2019-2030)
Figure 31. Global Androstenedione and Derivatives Average Price by Application (2019-2030) & (US$/kg)
Figure 32. North America Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 44. France Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Androstenedione and Derivatives Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Androstenedione and Derivatives Consumption Value Market Share by Region (2019-2030)
Figure 52. China Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 55. India Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 72. Androstenedione and Derivatives Market Drivers
Figure 73. Androstenedione and Derivatives Market Restraints
Figure 74. Androstenedione and Derivatives Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Androstenedione and Derivatives in 2023
Figure 77. Manufacturing Process Analysis of Androstenedione and Derivatives
Figure 78. Androstenedione and Derivatives Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Hubei Goto Biopharm
Saituo Biological Technology
Bayer
Rifa Pharma
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Androstenedione and Derivatives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Androstenedione and Derivatives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 83

Published Date: 02 Oct 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Androstenedione, or 4-androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).

Androstenedione derivatives refer to steroid hormone intermediates produced with androstenedione as the starting material, including testosterone, 17-hydroxyprogesterone, progesterone, canrenone, spironolactone, nandrolone, estrone, estradiol, estriol, etc.

According to our (Global Info Research) latest study, the global Androstenedione and Derivatives market size was valued at US$ 150 million in 2023 and is forecast to a readjusted size of USD 216 million by 2030 with a CAGR of 5.2% during review period.

This report is a detailed and comprehensive analysis for global Androstenedione and Derivatives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Androstenedione and Derivatives market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Androstenedione and Derivatives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Androstenedione and Derivatives market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Androstenedione and Derivatives market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Androstenedione and Derivatives
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Androstenedione and Derivatives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hubei Goto Biopharm, Saituo Biological Technology, Bayer, Rifa Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Androstenedione and Derivatives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Androstenedione
Androstenedione Derivatives

Market segment by Application
Sex Hormone Intermediates
Progesterone Intermediates

Major players covered
Hubei Goto Biopharm
Saituo Biological Technology
Bayer
Rifa Pharma

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Androstenedione and Derivatives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Androstenedione and Derivatives, with price, sales quantity, revenue, and global market share of Androstenedione and Derivatives from 2019 to 2024.
Chapter 3, the Androstenedione and Derivatives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Androstenedione and Derivatives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Androstenedione and Derivatives market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Androstenedione and Derivatives.
Chapter 14 and 15, to describe Androstenedione and Derivatives sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Androstenedione and Derivatives Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Androstenedione
1.3.3 Androstenedione Derivatives
1.4 Market Analysis by Application
1.4.1 Overview: Global Androstenedione and Derivatives Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Sex Hormone Intermediates
1.4.3 Progesterone Intermediates
1.5 Global Androstenedione and Derivatives Market Size & Forecast
1.5.1 Global Androstenedione and Derivatives Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Androstenedione and Derivatives Sales Quantity (2019-2030)
1.5.3 Global Androstenedione and Derivatives Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Hubei Goto Biopharm
2.1.1 Hubei Goto Biopharm Details
2.1.2 Hubei Goto Biopharm Major Business
2.1.3 Hubei Goto Biopharm Androstenedione and Derivatives Product and Services
2.1.4 Hubei Goto Biopharm Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Hubei Goto Biopharm Recent Developments/Updates
2.2 Saituo Biological Technology
2.2.1 Saituo Biological Technology Details
2.2.2 Saituo Biological Technology Major Business
2.2.3 Saituo Biological Technology Androstenedione and Derivatives Product and Services
2.2.4 Saituo Biological Technology Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Saituo Biological Technology Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Androstenedione and Derivatives Product and Services
2.3.4 Bayer Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Rifa Pharma
2.4.1 Rifa Pharma Details
2.4.2 Rifa Pharma Major Business
2.4.3 Rifa Pharma Androstenedione and Derivatives Product and Services
2.4.4 Rifa Pharma Androstenedione and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Rifa Pharma Recent Developments/Updates

3 Competitive Environment: Androstenedione and Derivatives by Manufacturer
3.1 Global Androstenedione and Derivatives Sales Quantity by Manufacturer (2019-2024)
3.2 Global Androstenedione and Derivatives Revenue by Manufacturer (2019-2024)
3.3 Global Androstenedione and Derivatives Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Androstenedione and Derivatives by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Androstenedione and Derivatives Manufacturer Market Share in 2023
3.4.3 Top 6 Androstenedione and Derivatives Manufacturer Market Share in 2023
3.5 Androstenedione and Derivatives Market: Overall Company Footprint Analysis
3.5.1 Androstenedione and Derivatives Market: Region Footprint
3.5.2 Androstenedione and Derivatives Market: Company Product Type Footprint
3.5.3 Androstenedione and Derivatives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Androstenedione and Derivatives Market Size by Region
4.1.1 Global Androstenedione and Derivatives Sales Quantity by Region (2019-2030)
4.1.2 Global Androstenedione and Derivatives Consumption Value by Region (2019-2030)
4.1.3 Global Androstenedione and Derivatives Average Price by Region (2019-2030)
4.2 North America Androstenedione and Derivatives Consumption Value (2019-2030)
4.3 Europe Androstenedione and Derivatives Consumption Value (2019-2030)
4.4 Asia-Pacific Androstenedione and Derivatives Consumption Value (2019-2030)
4.5 South America Androstenedione and Derivatives Consumption Value (2019-2030)
4.6 Middle East & Africa Androstenedione and Derivatives Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
5.2 Global Androstenedione and Derivatives Consumption Value by Type (2019-2030)
5.3 Global Androstenedione and Derivatives Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
6.2 Global Androstenedione and Derivatives Consumption Value by Application (2019-2030)
6.3 Global Androstenedione and Derivatives Average Price by Application (2019-2030)

7 North America
7.1 North America Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
7.2 North America Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
7.3 North America Androstenedione and Derivatives Market Size by Country
7.3.1 North America Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
7.3.2 North America Androstenedione and Derivatives Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
8.2 Europe Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
8.3 Europe Androstenedione and Derivatives Market Size by Country
8.3.1 Europe Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
8.3.2 Europe Androstenedione and Derivatives Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Androstenedione and Derivatives Market Size by Region
9.3.1 Asia-Pacific Androstenedione and Derivatives Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Androstenedione and Derivatives Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
10.2 South America Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
10.3 South America Androstenedione and Derivatives Market Size by Country
10.3.1 South America Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
10.3.2 South America Androstenedione and Derivatives Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Androstenedione and Derivatives Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Androstenedione and Derivatives Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Androstenedione and Derivatives Market Size by Country
11.3.1 Middle East & Africa Androstenedione and Derivatives Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Androstenedione and Derivatives Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Androstenedione and Derivatives Market Drivers
12.2 Androstenedione and Derivatives Market Restraints
12.3 Androstenedione and Derivatives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Androstenedione and Derivatives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Androstenedione and Derivatives
13.3 Androstenedione and Derivatives Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Androstenedione and Derivatives Typical Distributors
14.3 Androstenedione and Derivatives Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Androstenedione and Derivatives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Androstenedione and Derivatives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Hubei Goto Biopharm Basic Information, Manufacturing Base and Competitors
Table 4. Hubei Goto Biopharm Major Business
Table 5. Hubei Goto Biopharm Androstenedione and Derivatives Product and Services
Table 6. Hubei Goto Biopharm Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Hubei Goto Biopharm Recent Developments/Updates
Table 8. Saituo Biological Technology Basic Information, Manufacturing Base and Competitors
Table 9. Saituo Biological Technology Major Business
Table 10. Saituo Biological Technology Androstenedione and Derivatives Product and Services
Table 11. Saituo Biological Technology Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Saituo Biological Technology Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Androstenedione and Derivatives Product and Services
Table 16. Bayer Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Rifa Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Rifa Pharma Major Business
Table 20. Rifa Pharma Androstenedione and Derivatives Product and Services
Table 21. Rifa Pharma Androstenedione and Derivatives Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Rifa Pharma Recent Developments/Updates
Table 23. Global Androstenedione and Derivatives Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 24. Global Androstenedione and Derivatives Revenue by Manufacturer (2019-2024) & (USD Million)
Table 25. Global Androstenedione and Derivatives Average Price by Manufacturer (2019-2024) & (US$/kg)
Table 26. Market Position of Manufacturers in Androstenedione and Derivatives, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 27. Head Office and Androstenedione and Derivatives Production Site of Key Manufacturer
Table 28. Androstenedione and Derivatives Market: Company Product Type Footprint
Table 29. Androstenedione and Derivatives Market: Company Product Application Footprint
Table 30. Androstenedione and Derivatives New Market Entrants and Barriers to Market Entry
Table 31. Androstenedione and Derivatives Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Androstenedione and Derivatives Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 33. Global Androstenedione and Derivatives Sales Quantity by Region (2019-2024) & (Tons)
Table 34. Global Androstenedione and Derivatives Sales Quantity by Region (2025-2030) & (Tons)
Table 35. Global Androstenedione and Derivatives Consumption Value by Region (2019-2024) & (USD Million)
Table 36. Global Androstenedione and Derivatives Consumption Value by Region (2025-2030) & (USD Million)
Table 37. Global Androstenedione and Derivatives Average Price by Region (2019-2024) & (US$/kg)
Table 38. Global Androstenedione and Derivatives Average Price by Region (2025-2030) & (US$/kg)
Table 39. Global Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 40. Global Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 41. Global Androstenedione and Derivatives Consumption Value by Type (2019-2024) & (USD Million)
Table 42. Global Androstenedione and Derivatives Consumption Value by Type (2025-2030) & (USD Million)
Table 43. Global Androstenedione and Derivatives Average Price by Type (2019-2024) & (US$/kg)
Table 44. Global Androstenedione and Derivatives Average Price by Type (2025-2030) & (US$/kg)
Table 45. Global Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 46. Global Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 47. Global Androstenedione and Derivatives Consumption Value by Application (2019-2024) & (USD Million)
Table 48. Global Androstenedione and Derivatives Consumption Value by Application (2025-2030) & (USD Million)
Table 49. Global Androstenedione and Derivatives Average Price by Application (2019-2024) & (US$/kg)
Table 50. Global Androstenedione and Derivatives Average Price by Application (2025-2030) & (US$/kg)
Table 51. North America Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 52. North America Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 53. North America Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 54. North America Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 55. North America Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 56. North America Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 57. North America Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 58. North America Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Europe Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 60. Europe Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 61. Europe Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 62. Europe Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 63. Europe Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 64. Europe Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 65. Europe Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 66. Europe Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 67. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 68. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 69. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 70. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 71. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Region (2019-2024) & (Tons)
Table 72. Asia-Pacific Androstenedione and Derivatives Sales Quantity by Region (2025-2030) & (Tons)
Table 73. Asia-Pacific Androstenedione and Derivatives Consumption Value by Region (2019-2024) & (USD Million)
Table 74. Asia-Pacific Androstenedione and Derivatives Consumption Value by Region (2025-2030) & (USD Million)
Table 75. South America Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 76. South America Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 77. South America Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 78. South America Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 79. South America Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 80. South America Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 81. South America Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Type (2019-2024) & (Tons)
Table 84. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Type (2025-2030) & (Tons)
Table 85. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Application (2019-2024) & (Tons)
Table 86. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Application (2025-2030) & (Tons)
Table 87. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Country (2019-2024) & (Tons)
Table 88. Middle East & Africa Androstenedione and Derivatives Sales Quantity by Country (2025-2030) & (Tons)
Table 89. Middle East & Africa Androstenedione and Derivatives Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Middle East & Africa Androstenedione and Derivatives Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Androstenedione and Derivatives Raw Material
Table 92. Key Manufacturers of Androstenedione and Derivatives Raw Materials
Table 93. Androstenedione and Derivatives Typical Distributors
Table 94. Androstenedione and Derivatives Typical Customers


List of Figures
Figure 1. Androstenedione and Derivatives Picture
Figure 2. Global Androstenedione and Derivatives Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Androstenedione and Derivatives Revenue Market Share by Type in 2023
Figure 4. Androstenedione Examples
Figure 5. Androstenedione Derivatives Examples
Figure 6. Global Androstenedione and Derivatives Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Androstenedione and Derivatives Revenue Market Share by Application in 2023
Figure 8. Sex Hormone Intermediates Examples
Figure 9. Progesterone Intermediates Examples
Figure 10. Global Androstenedione and Derivatives Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Androstenedione and Derivatives Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Androstenedione and Derivatives Sales Quantity (2019-2030) & (Tons)
Figure 13. Global Androstenedione and Derivatives Price (2019-2030) & (US$/kg)
Figure 14. Global Androstenedione and Derivatives Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Androstenedione and Derivatives Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Androstenedione and Derivatives by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 Androstenedione and Derivatives Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 Androstenedione and Derivatives Manufacturer (Revenue) Market Share in 2023
Figure 19. Global Androstenedione and Derivatives Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Androstenedione and Derivatives Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Androstenedione and Derivatives Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Androstenedione and Derivatives Average Price by Type (2019-2030) & (US$/kg)
Figure 29. Global Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Androstenedione and Derivatives Revenue Market Share by Application (2019-2030)
Figure 31. Global Androstenedione and Derivatives Average Price by Application (2019-2030) & (US$/kg)
Figure 32. North America Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 44. France Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Androstenedione and Derivatives Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Androstenedione and Derivatives Consumption Value Market Share by Region (2019-2030)
Figure 52. China Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 55. India Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Androstenedione and Derivatives Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Androstenedione and Derivatives Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Androstenedione and Derivatives Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa Androstenedione and Derivatives Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa Androstenedione and Derivatives Consumption Value (2019-2030) & (USD Million)
Figure 72. Androstenedione and Derivatives Market Drivers
Figure 73. Androstenedione and Derivatives Market Restraints
Figure 74. Androstenedione and Derivatives Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Androstenedione and Derivatives in 2023
Figure 77. Manufacturing Process Analysis of Androstenedione and Derivatives
Figure 78. Androstenedione and Derivatives Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Hubei Goto Biopharm
Saituo Biological Technology
Bayer
Rifa Pharma
jiaGou

Add To Cart

gouMai

Buy Now